Google
EDAP 株価分析 — EDAP TMS SA (Healthcare >> Medical Distribution)
EDAP に関するよくある質問
EDAPのROE（自己資本利益率）は？
EDAP TMS SAのROEは-297.24%です。
EDAPの配当利回りは？
EDAP TMS SAの配当利回りは0.00%です。
EDAPの品質スコア（Quality Score）は？
当社のAIはEDAPの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
EDAPは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
EDAPはどのセクターに属しますか？
EDAP TMS SAはHealthcare >> Medical Distributionセクターに分類されます（NASDAQ市場）
EDAP AI Analysis Summary
Our AI summary for EDAP: EDAP TMS SA (NASDAQ), Healthcare >> Medical Distribution sector. The stock currently trades at a P/E of 0.00, ROE of -297.24%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 4.77
Price
0.07
(1.49%)
Day Change
|
|
|---|
EDAP, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 59 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.77 |
| PBV / Sector |
16.03 / -7.19
|
| Earning Per Share | -0.88 |
| PE / Sector |
N/A / 20.35
|
| PEG or PE/Growth / Sector |
N/A / 211.57
|
| Average 1M Daily Value |
0.16 M
GREAT
|
| Average 1W Daily Value |
0.22 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:45 |
| Symbol | EDAP |
| Name | EDAP TMS SA |
| Sector | Healthcare >> Medical Distribution |
| Market | NASDAQ |
| Listed Shares | 37.48 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 161.92 / 45,764.92 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Parc d?Activites la Poudrette-Lamartine, Vaulx-en-Velin, France, 69120
Phone: 33 4 72 15 31 50
Website: https://focalone.com
Employees: 289
Description: EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales channels, and third-party distributors and agents. The company serves academic, public, and private hospitals, as well as clinics. The company has a strategic collaboration with Telix Pharmaceuticals Limited to develop clinical workflows combining PSMA PET imaging and Focal One Robotic HIFU for prostate cancer. EDAP TMS S.A. was incorporated in 1979 and is headquartered in Vaulx-en-Velin, France.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Distribution
Click a bubble to view stock details · Bubble size represents market capitalization share
